{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:37:58Z","timestamp":1784295478559,"version":"3.55.0"},"reference-count":57,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Project of Institutional Financing of the Faculty of Medicine, University of Belgrade","award":["451-03-66\/2024-03\/200110"],"award-info":[{"award-number":["451-03-66\/2024-03\/200110"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Clinical differentiation between Parkinson\u2019s disease (PD) and atypical parkinsonism (AP) remains complex. Current diagnostic procedures helpful in their distinction lack specificity, making non-invasive tools like optical coherence tomography (OCT) crucial in evaluating possible retinal changes as potential biomarkers. Our study examined the thickness of the ganglion cell inner plexiform layer complex (GCIPL), peripapillary retinal nerve fiber layer (RNFL) and macular segments in individuals with PD, multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and healthy controls (HC). The objective of our study was to determine if OCT analyses can effectively discriminate PD patients from HC and whether retinal thickness can distinguish typical PD patients from those with AP. Methods: Research was an observational, cross-sectional study. Multiple retinal layers measured with OCT of PD and AP patients were compared with age- and sex-matched HC. An intergroup assessment was conducted. Results: Patients with PD and PSP exhibit a thinner GCIPL compared to HC, with no difference observed in the MSA group. GCIPL thickness between investigational groups does not differentiate between PD and AP. The RNFL and central macula thickness were statistically significantly reduced in all patient groups compared to HC. The RNFL was thinner in PSP compared to PD. Nearly all inner and outer macular segments were thinner in the investigational groups compared to HC. The preservation of outer nasal segments distinguished HC from both typical and AP. Patients with PSP and PD differed in the thickness of all macular segments, being thinner in PSP patients. Conclusions: Thickness of multiple retinal layers and macular regions might serve as a distinguishing feature between PD, AP and HC.<\/jats:p>","DOI":"10.3390\/biomedicines14010249","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:55:34Z","timestamp":1769176534000},"page":"249","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retinal Thickness Profiles in Parkinsonian Syndromes: Discerning Parkinson\u2019s Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy via Optical Coherence Tomography"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8315-8869","authenticated-orcid":false,"given":"Marko","family":"Svetel","sequence":"first","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-142X","authenticated-orcid":false,"given":"Gorica","family":"Mari\u0107","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Bo\u017ei\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pekmezovi\u0107","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2669-8251","authenticated-orcid":false,"given":"Igor","family":"Petrovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic for Neurology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Jak\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4401-7297","authenticated-orcid":false,"given":"Ana","family":"Dimitrijevi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Lazi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Neurology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smiljana","family":"Kosti\u0107","sequence":"additional","affiliation":[{"name":"Neurology Clinic, Military Medical Academy, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Kne\u017eevi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiana","family":"Petrovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja Petrovi\u0107","family":"Paji\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"\u0160obot","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4806-0497","authenticated-orcid":false,"given":"Jelena","family":"Vasilijevi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Eye Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Svetel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic for Neurology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson Pandemic-A Call to Action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"Respondek","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.27034","article-title":"Which ante mortem clinical features predict progressive supranuclear palsy pathology?","volume":"32","author":"Respondek","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_9","first-page":"61","article-title":"The Differential Diagnosis and Treatment of Atypical Parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.24182","article-title":"\u03b1-synuclein in the inner retina in parkinson disease","volume":"75","author":"Kozlowski","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_11","first-page":"s00431777775","article-title":"The clinical diagnosis of Parkinson\u2019s disease","volume":"82","author":"Munhoz","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: Towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: The SynNeurGe research diagnostic criteria","volume":"23","author":"Adler","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1007\/s00415-022-11014-0","article-title":"Undetected ophthalmological disorders in Parkinson\u2019s disease","volume":"269","author":"Borm","year":"2022","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/CPJ.0000000000000719","article-title":"Visual tests predict dementia risk in Parkinson disease","volume":"10","author":"Leyland","year":"2020","journal-title":"Neurol. Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bjophthalmol-2021-320618","article-title":"Retinal nerve fibre layer thickness measured with SD-OCT in a population-based study: The Handan Eye Study","volume":"107","author":"Wu","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Deng, Y., Jie, C., Wang, J., Liu, Z., Li, Y., and Hou, X. (2022). Evaluation of retina and microvascular changes in the patient with Parkinson\u2019s disease: A systematic review and meta-analysis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.957700"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","article-title":"Ophir, Retinal nerve fiber layer thinning in Parkinson disease","volume":"44","author":"Inzelberg","year":"2004","journal-title":"Vis. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5301\/EJO.2010.1318","article-title":"Morphologic Changes and Functional Retinal Impairment in Patients with Parkinson Disease without Visual Loss","volume":"21","author":"Moschos","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.parkreldis.2011.03.004","article-title":"Retinal thickness in Parkinson\u2019s disease","volume":"17","author":"Archibald","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"ref_21","first-page":"197","article-title":"Optical coherence tomography in Parkinson\u2019s disease: Is the retina a biomarker?","volume":"4","author":"Lee","year":"2014","journal-title":"J. Park. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ene.14613","article-title":"Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"28","author":"Zhou","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13760-019-01228-x","article-title":"Evaluation of retinal alterations in Parkinson disease and tremor diseases","volume":"120","author":"Tugcu","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rascun\u00e0, C., Russo, A., Terravecchia, C., Castellino, N., Avitabile, T., Bonfiglio, V., Fallico, M., Chisari, C.C., Cicero, C.E., and Grillo, M. (2020). Retinal Thickness and Microvascular Pattern in Early Parkinson\u2019s Disease. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.533375"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1007\/s00415-020-10304-9","article-title":"Central retina changes in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"268","author":"Huang","year":"2021","journal-title":"J. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41531-022-00325-8","article-title":"The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson\u2019s disease","volume":"8","author":"Wang","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104379","DOI":"10.1016\/j.jfo.2024.104379","article-title":"Optical coherence tomography (OCT) findings in patients with Parkinson\u2019s disease presenting to Farshchian Hospital (Sina) in 2019 compared to the normal population","volume":"48","author":"Eslami","year":"2024","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Poveda, S., Arellano, X., Bernal-Pacheco, O., and Valencia L\u00f3pez, A. (2024). Structural changes in the retina as a potential biomarker in Parkinson\u2019s disease: An approach from optical coherence tomography. Front. Neuroimaging, 3.","DOI":"10.3389\/fnimg.2024.1340754"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e35354","DOI":"10.1097\/MD.0000000000035354","article-title":"Central retina thickness measured with spectral-domain optical coherence tomography in Parkinson disease: A meta-analysis","volume":"102","author":"Lee","year":"2023","journal-title":"Medicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1581","DOI":"10.1212\/WNL.0000000000207727","article-title":"Retinal Optical Coherence Tomography Features Associated with Incident and Prevalent Parkinson Disease","volume":"101","author":"Wagner","year":"2023","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00415-021-10703-6","article-title":"Retina thickness in atypical parkinsonism: A systematic review and meta-analysis","volume":"269","author":"Ma","year":"2022","journal-title":"J. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ma, X., Li, S., Zheng, B., Hu, L., Liu, H., Wang, Z., Wang, Z., Chen, H., and Su, W. (2023). Retinal Structure Abnormalities in Parkinson\u2019s Disease and Atypical Parkinsonism. Biomolecules, 13.","DOI":"10.3390\/biom13020218"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1038\/s41598-020-66497-6","article-title":"\u03b1-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells","volume":"10","author":"Marrocco","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/aian.AIAN_152_18","article-title":"Optical Coherence Tomography Findings in Patients of Parkinson\u2019s Disease: An Indian Perspective","volume":"21","author":"Sengupta","year":"2018","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.parkreldis.2015.08.002","article-title":"Optical coherence tomography as a tool to evaluate retinal changes in Parkinson\u2019s disease","volume":"21","author":"Mailankody","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1111\/aos.12757","article-title":"Detection of retinal changes in idiopathic Parkinson\u2019s disease using high-resolution optical coherence tomography and heidelberg retina tomography","volume":"93","author":"Bittersohl","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/ijo.IJO_1409_21","article-title":"Assessment of retinal manifestations of Parkinson\u2019s disease using spectral domain optical coherence tomography: A study in Indian eyes","volume":"70","author":"Verghese","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00415-020-10094-0","article-title":"The specific pattern of retinal nerve fiber layer thinning in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"268","author":"Huang","year":"2021","journal-title":"J. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00702-019-02097-7","article-title":"Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-na\u00efve Parkinson\u2019s disease","volume":"126","author":"Lee","year":"2019","journal-title":"J. Neural Transm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25543","article-title":"Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s Disease","volume":"29","author":"Lee","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","article-title":"Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease","volume":"116","author":"Ozkan","year":"2008","journal-title":"Doc. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2013.4","article-title":"Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients","volume":"27","author":"Satue","year":"2013","journal-title":"Eye"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/mds.26360","article-title":"Progressive retinal structure abnormalities in multiple system atrophy","volume":"30","author":"Palma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","article-title":"The neuropathology, pathophysiology and genetics of multiple system atrophy","volume":"38","author":"Ahmed","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00702-013-1072-3","article-title":"Retinal single-layer analysis in Parkinsonian syndromes: An optical coherence tomography study","volume":"121","author":"Schneider","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Albrecht, P., M\u00fcller, A.K., S\u00fcdmeyer, M., Ferrea, S., Ringelstein, M., Cohn, E., Aktas, O., Dietlein, T., Lappas, A., and Foerster, A. (2012). Optical coherence tomography in parkinsonian syndromes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034891"},{"key":"ref_49","unstructured":"Kolb, H., Fernandez, E., and Nelson, R. (2012). Simple anatomy of the retina. Webvision: The Organization of the Retina and Visual System, University of Utah Health Sciences Center."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00415-016-8230-0","article-title":"Retinal thinning correlates with clinical severity in multiple system atrophy","volume":"263","author":"Ahn","year":"2016","journal-title":"J. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1038\/s41598-017-05575-8","article-title":"Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry","volume":"7","author":"Stemplewitz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3233\/JAD-201139","article-title":"Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration","volume":"79","author":"Harrington","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/NEN.0b013e31820376cc","article-title":"Protein aggregation in the aging retina","volume":"70","author":"Leger","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105635","DOI":"10.1016\/j.clineuro.2019.105635","article-title":"Optical coherence tomography of patients with Parkinson\u2019s disease and progressive supranuclear palsy","volume":"189","author":"Alkabie","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNO.0000000000000591","article-title":"Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease","volume":"38","author":"Unlu","year":"2018","journal-title":"J. Neuroophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1038\/s41598-019-48388-7","article-title":"Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson\u2019s disease","volume":"9","author":"Sung","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.kjms.2017.11.006","article-title":"Optical coherence tomography findings in Parkinson\u2019s disease","volume":"34","author":"Aydin","year":"2018","journal-title":"Kaohsiung J. Med. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/249\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:18:30Z","timestamp":1769177910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biomedicines14010249"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14010249","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}